Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection Images
Generic Name: ranibizumab
This medication has been identified as Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection. It is supplied by Biogen.
Byooviz is used in the treatment of Macular Degeneration; Macular Edema Following Retinal Vein Occlusion ; Macular Edema; Myopic Choroidal Neovascularization and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Byooviz
- Generic Name
- ranibizumab
- Strength
- 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Biogen
- National Drug Code (NDC)
- 64406-0019
More about Byooviz (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
